Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03240601 · ClinicalTrials.gov registry record · NA

Spinal Cord Stimulation to Augment Activity Based Therapy

A NA study of Spinal Cord Injuries and Spasticity, sponsored by Shepherd Center, Atlanta GA.

Completed
Registry status
NA
Development phase
18
Enrollment target
1
Study location

NCT03240601: Completed NA study of Spinal Cord Injuries and Spasticity, sponsored by Shepherd Center, Atlanta GA.

NCT03240601 is a NA study of Spinal Cord Injuries and Spasticity that has completed, run by Shepherd Center, Atlanta GA. The registered enrollment target is 18 participants, below the 62-participant average among 202 other Spinal Cord Injuries trials with a reported enrollment target (71% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03240601, a NA study of Spinal Cord Injuries and Spasticity, has completed, sponsored by Shepherd Center, Atlanta GA.

COMPLETED
Registry status
NA
Development phase
18 participants
Enrollment target
1
Study location

Study Summary

Involuntary muscle activity, often called spasticity, is a common problem following spinal cord injury (SCI) that can make it hard to move. Many things can cause spasticity including: muscle stretch, movement, or it can happen for no reason, and it is often described as an uncontrolled muscle spasm or feeling of stiffness. Drugs are typically used to treat spasticity, but they often have side effects, like muscle weakness, which can add to movement problems. Rehabilitation therapies offer alternatives to drugs for treating involuntary muscle activity, and rehabilitation can also improve daily function and quality of life. These benefits may be greater when several rehabilitation therapies are used together. Walking ability can be improved with a type of therapy called "locomotor training". This type of therapy may also have the benefit of decreasing spasticity. When locomotor training (LT) is combined with electrical stimulation, the benefits of training may be increased. In this study, investigators will use a kind of stimulation called transcutaneous spinal cord stimulation ("TSS") to stimulate participants' spinal cord nerves during locomotor training.

Primary Outcome

You will walk over a mat that contains sensors to measure your walking speed as well as wear motion tracking sensors. You will be allowed to use whatever assistive devices you typically use (e.g., braces, walker, forearm crutches). In addition to walking speed, we will also assess your gait kinematics.

Interventions

  • DEVICE Transcutaneous spinal stimulation

Study Locations (1)

Georgia

  • Shepherd Center, Inc. - Atlanta

Trial Details

FieldValue
Enrollment Target 18 participants
Start Date 2017-07-01
Est. Completion 2019-09-11
Phase NA
Shepherd Center, Atlanta GA

17 total trials

What the finished NCT03240601 record still lists

NCT03240601 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 18 participants, a relatively small participant target, below the 62-participant average among 202 other Spinal Cord Injuries trials with a reported enrollment target (71% lower).

The record links to 5 conditions, with Spinal Cord Injuries appearing as the primary indexed condition, and to 1 intervention - of which Transcutaneous spinal stimulation is the first listed.

NCT03240601 reports a single indexed study location in Georgia.

Frequently Asked Questions

What is clinical trial NCT03240601 about?

NCT03240601 is a clinical study titled "Spinal Cord Stimulation to Augment Activity Based Therapy". Involuntary muscle activity, often called spasticity, is a common problem following spinal cord injury (SCI) that can make it hard to move. Many things can cause spasticity including: muscle stretch, movement, or it can happen for no reason, and it is often described as an uncontrolled muscle spasm ...

What is the current status of trial NCT03240601?

This trial is currently completed. It is a NA study. The enrollment target is 18 participants. The study started on 2017-07-01. Estimated completion is 2019-09-11.

What conditions does trial NCT03240601 study?

This clinical trial studies the following conditions: Spinal Cord Injuries, Spasticity, Transcutaneous Spinal Stimulation, Walking, Human.

What interventions are being tested in trial NCT03240601?

The interventions under investigation include: Transcutaneous spinal stimulation (DEVICE).

Who is sponsoring clinical trial NCT03240601?

This trial is sponsored by Shepherd Center, Atlanta GA, which has 17 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03240601 being conducted?

This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Spinal Cord Injuries

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03240601's enrollment target sits among peer trials

18 139th of 202 higher than 61 of 202 other Spinal Cord Injuries trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Spinal Cord Injuries trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01245179 · 18 participants · Phase 1

    Study of Panobinostat (LBH589) in Patients With Sickle Cell Disease

  • NCT01999361 · 18 participants · NA

    Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft Loss

  • NCT02359825 · 18 participants · Phase 1

    Nerve Repair Using Hydrophilic Polymers to Promote Immediate Fusion of Severed Axons and Swift Return of Function

  • NCT02870244 · 18 participants · Phase 1

    Adoptive T Cell Immunotherapy for Advanced Melanoma Using Engineered Lymphocytes

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT06358040 · started 2026-10 · NA

    Opioid Dispenser for Microdiscectomy/Laminectomy

Source: ClinicalTrials.gov NCT03240601, the US trial registry maintained by the National Library of Medicine. NCT03240601 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.